Featured AgeX Therapeutics Skyrockets Up 250% After Juvenescence Discloses 50% Stake in AGE AgeX leads the market with over 253 million shares being traded as the stock crosses $3 mark since July 2019.
Taiwan Liposome (TLC) Jumps Above 30% as It Attains Approval to Initiate COVID-19 Treatment Trial Australian and Taiwan approval for TLC19 comes after the acceptance of TLC’s investigational new drug application. Shares of Taiwan Liposome